The landscape of dementia prognosis has advanced substantially with the advent of advanced biomarkers, such as amyloid PET scans, tau imaging, and blood-centered tests which will detect Alzheimer's pathology many years in advance of signs and symptoms arise. Though these technological developments signify exceptional progress in comprehension neuro